Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Letter to the Editor: A Report of Early-onset Psychosis Occurring in the Context of a Perinatal Stroke History
Dear Editor: Although poststroke psychosis is a reasonably well-established clinical phenomenon,1 few articles describing the development of psychotic symptoms on the background of a perinatal stroke history or other anoxic brain injury have been published [...]
Letter to the Editor: A First Seizure After 2,000mg Fluoxetine May or May Not Be Due to Intoxication
Dear Editor: I read with interest the article by Allen et al1 about a 19-year-old male transgender patient who developed seizures after intentionally taking 2,000mg of fluoxetine. His medical history was positive for major depressive [...]
Letter to the Editor: Response to “A First Seizure After 2,000mg Fluoxetine May or May Not be Due to Intoxication”
Dear Editor: We thank the author for their thoughtful and insightful comments on our case report.1 We fully agree that fluoxetine has a known potential to trigger seizures, especially in overdose situations. In our patient, [...]
Cultural Concepts of Distress: A Dive into Presentation and Avenues for Management
by Rahi Patel, MD; Amin Ashraf, BS; Nicholas Myers, BS; and Nita Bhatt, MD, MPH Dr. Patel is with Beth Israel Deaconess Medical Center at Harvard Medical School in Boston, Massachusetts. Mr. Ashraf and Mr. [...]
Office-based Neurophysiological Assessments for Diagnosis and Prognosis of Concussion
Innov Clin Neurosci. 2025;22(7–9):18–23. by Robert G. Bashuk, MD; Stephen L. Scranton, MD, FACP; Robert S. Allen, AuD, and Marco Cecchi, PhD Drs. Bashuk and Allen are with the Concussion Center in Atlanta, Georgia. Dr. [...]
Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study
Innov Clin Neurosci. 2025;22(7–9):24–27. by Muqadas Fatima, MS, and Uzma Ilyas, PhD Ms. Fatima is serving as Lecturer at National University of Modern Languages (NUML) in Lahore, Pakistan. Dr. Ilyas is Senior Lecturer at Forman [...]
Helping Exceptionally Sensitive Patients See Their Sensitivity as a Gift
Innov Clin Neurosci. 2025;22(7–9):28–31. by Edmund G. Howe, MD, JD Dr. Howe is with Uniformed Services University of the Health Sciences in Bethesda, Maryland. FUNDING: No funding was provided for this article. DISCLOSURES: The author [...]
Past Articles
Letter to the Editor: Before Attributing Compulsive Chewing to Amphetamines, Alternative Causes Must Be Thoroughly Ruled Out
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: We read with interest the article by Free et al1 about a 32-year-old female patient with a history of migraine, gastroesophageal reflux disease (GERD) and gastroparesis, attention deficit hyperactivity [...]
Letter to the Editor: Response to “Before Attributing Compulsive Chewing to Amphetamines, Alternative Causes Must Be Thoroughly Ruled Out”
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: We greatly appreciate the letter to the editor regarding the article “Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report” by Free et al,1 as it provides [...]
Letter to the Editor: Challenges of Psychiatric Diagnostic Support Using Functional Near-infrared Spectroscopy
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: Approximately 15 years have passed since functional near-infrared spectroscopy (fNIRS) was approved for use as an auxiliary diagnostic tool for the differential diagnosis of depressive state in psychiatry by [...]
Validation of a Clinical Decision Support Tool for Quantifying Risk of Torsades de Pointes in a Psychiatric Inpatient Population
by Samara White, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN Drs. White and Demler are with The New York State Office of Mental Health at Buffalo Psychiatric [...]
Measurement-based Care Training Curriculum in Psychiatry Residency Programs: Four-year Implementation Experience and Future Directions
by Ahmed Aboraya, MD, DrPH; Daniel Elswick, MD; James Berry, DO; Dilip Chandran, MD; Cheryl Hill, MD; Wanhong Zheng, MD; Jeremy D. Hustead, MD; Dorothy Van Oppen, MD; Vishal Patel, MD; Sara Berzingi, MD; Karen [...]
Risk Management: I’ve Been Sued, Now What! Part 2
by Charles D. Cash, JD, LLM Mr. Cash is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is [...]
Letter to the Editor: More Evidence is Needed Before Recommending Magic Mushrooms for the Treatment of Complicated Migraines
Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: I read with interest Lawrence’s article about a 33-year-old male patient with migraine with aura who self-experimented with psilocybin for his migraine attacks, which occurred at a frequency of [...]